OPTINOSE INC. - COMMO
0,5001
29-ноября-24 12:00:05
15 мин. задержка
Акции
-0,0356
-6,65%
Сегодняшний диапазон
0,4600 - 0,5655
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Optinose to Present at the 35th Annual Piper Sandler Healthcare Conference
22 ноя 2023 08:00:00 Источник Nasdaq GlobeNewswire
-
Optinose Reports Third Quarter 2023 Financial Results and Operational Updates
09 ноя 2023 06:00:00 Источник Nasdaq GlobeNewswire
-
Optinose Announces Reporting Date for Third Quarter 2023 Financial Results
27 окт 2023 07:00:00 Источник Nasdaq GlobeNewswire
-
Optinose to Present at the 2023 Cantor Global Healthcare Conference
22 сен 2023 08:01:00 Источник Nasdaq GlobeNewswire
-
Optinose Reports Second Quarter 2023 Financial Results and Operational Updates
10 авг 2023 06:00:00 Источник Nasdaq GlobeNewswire
-
Optinose Announces Preliminary Second Quarter 2023 XHANCE Net Revenue of $19.5 Million
27 июл 2023 06:00:01 Источник Nasdaq GlobeNewswire
-
Optinose Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
16 июн 2023 15:08:00 Источник Nasdaq GlobeNewswire
-
Optinose to Present at the Jefferies Healthcare Conference
02 июн 2023 12:00:00 Источник Nasdaq GlobeNewswire
-
Optinose Reports First Quarter 2023 Financial Results and Operational Updates
11 май 2023 06:00:18 Источник Nasdaq GlobeNewswire
-
Optinose Announces FDA Acceptance of Supplemental New Drug Application for XHANCE
04 май 2023 06:00:01 Источник Nasdaq GlobeNewswire
-
Optinose Announces Reporting Date for First Quarter 2023 Financial Results
01 май 2023 15:30:00 Источник Nasdaq GlobeNewswire
-
Optinose Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
18 апр 2023 07:00:01 Источник Nasdaq GlobeNewswire
-
Optinose to Present at the Needham Virtual Healthcare Conference
12 апр 2023 15:00:00 Источник Nasdaq GlobeNewswire
-
07 мар 2023 06:00:56 Источник Nasdaq GlobeNewswire
-
Optinose Announces Reporting Date for Fourth Quarter 2022 Financial Results
28 фев 2023 15:30:00 Источник Nasdaq GlobeNewswire
-
Optinose Submits Supplemental New Drug Application for XHANCE Label Expansion
21 фев 2023 06:00:01 Источник Nasdaq GlobeNewswire
-
Optinose Announces CEO Transition and Business Update
31 янв 2023 06:00:01 Источник Nasdaq GlobeNewswire
-
Optinose Appoints Paul Spence as Chief Commercial Officer
15 дек 2022 15:30:00 Источник Nasdaq GlobeNewswire
-
Optinose Announces Departure of Acting Chief Financial Officer
09 дек 2022 07:00:00 Источник Nasdaq GlobeNewswire
-
30 ноя 2022 06:00:00 Источник Nasdaq GlobeNewswire